National Research (NASDAQ:NRC) Shares Down 8.4%

National Research Co. (NASDAQ:NRC)’s share price fell 8.4% during trading on Wednesday . The stock traded as low as $32.51 and last traded at $32.62. 13,068 shares were traded during mid-day trading, a decline of 81% from the average session volume of 68,995 shares. The stock had previously closed at $35.63.

Wall Street Analysts Forecast Growth

Separately, TheStreet cut National Research from a “b-” rating to a “c+” rating in a report on Thursday, January 11th.

National Research Stock Down 16.5 %

The stock’s fifty day simple moving average is $37.36 and its 200-day simple moving average is $39.27. The stock has a market cap of $709.78 million, a P/E ratio of 26.90 and a beta of 0.45. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.67 and a current ratio of 0.67.

National Research (NASDAQ:NRC) last released its earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share for the quarter. The firm had revenue of $38.00 million during the quarter. National Research had a return on equity of 47.79% and a net margin of 20.84%.

National Research Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Friday, March 29th were issued a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.61%. National Research’s dividend payout ratio (DPR) is currently 38.40%.

Institutional Trading of National Research

Several large investors have recently bought and sold shares of NRC. iA Global Asset Management Inc. bought a new stake in shares of National Research during the third quarter worth $11,124,000. Comerica Bank acquired a new position in National Research in the 3rd quarter valued at approximately $6,939,000. Norden Group LLC bought a new position in shares of National Research during the first quarter valued at $5,170,000. PineStone Asset Management Inc. lifted its holdings in shares of National Research by 128.9% during the fourth quarter. PineStone Asset Management Inc. now owns 153,100 shares of the company’s stock worth $6,057,000 after purchasing an additional 86,202 shares during the period. Finally, Conestoga Capital Advisors LLC raised its position in National Research by 6.0% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 773,215 shares of the company’s stock worth $34,308,000 after purchasing an additional 43,475 shares during the last quarter. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.